Page: 13 of 30 9 10 11 12 13 14 15 16 17

Jan Geissler, Director, European Cancer Patient Coalition Channel: www.ecancer.tv Length: 0 Date: June 25, 2010 Jan Geissler discusses the role of patient advocacy groups and the efforts being made to help improve the spread and accessibility of information f...

Prof Hedy Kindler – University of Chicago, USA Channel: www.ecancer.tv Length: 0 Date: June 25, 2010 Prof Hedy Kindler outlines the results of a randomised phase II trial investigating the use of conatumumab or AMG 479 as a treatment for pancreatic...

Dr Fabrice André Channel: www.ecancer.tv Length: 0 Date: June 11, 2010 Dr Fabrice André - Continuous ErbB2 suppression - what options do we have? - Treatment Beyond the Current Paradigm, New Outlooks in Breast Cancer

Dr Maurizio Scaltriti Channel: www.ecancer.tv Length: 0 Date: June 11, 2010 Satellite Symposium: Treatment Beyond the Current Paradigm, New Outlooks in Breast CancerOfficial EBCC-7 Sponsored Satellite Symposium

Dr Antonio Llombart Cussac Channel: www.ecancer.tv Length: 0 Date: June 11, 2010 Dr Antonio Llombart Cussac - Dr Antonio Llombart Cussac - Treatment Beyond the Current Paradigm, New Outlooks in Breast Cancer

Dr Alison Jones Channel: www.ecancer.tv Length: 0 Date: June 11, 2010 Dr Alison Jones - Treatment Beyond the Current Paradigm - New outlooks in Breast Cancer

Prof Gordon McVie; European Institute of Oncology, Milan Channel: www.ecancer.tv Length: 0 Date: June 11, 2010 Prof Gordon McVie discusses the advances presented at this years ASCO conference. These include: the development of Ipilimumab, an antibody agains...

Prof Christopher Twelves; Leeds Institute of Molecular Medicine and St. James’s Institute of Oncology, Leeds, UK Channel: www.ecancer.tv Length: 0 Date: June 11, 2010 Prof Christopher Twelves, speaking at the 2010 ASCO conference: A Phase III randomised trial finds that a new chemotherapy agent, eribulin mesylat...

Prof Yung-Jue Bang, Seoul National University College of Medicine, Seoul, Korea Channel: www.ecancer.tv Length: 0 Date: June 11, 2010 Prof Yung-Jue Bang, speaking at the 2010 ASCO conference: A study featured in an ASCO plenary session shows that the majority of patients with adv...

Dr Steven O’Day; The Angeles Clinic and Research Institute, Santa Monica, California Channel: www.ecancer.tv Length: 0 Date: June 11, 2010 Dr Steven O’Day, speaking at the 2010 ASCO conference: A Phase III trial featured in an ASCO plenary session finds that patients with advanced, pr...

Prof Robert A. Burger; Fox Chase Cancer Center Philadelphia, Pennsylvania Channel: www.ecancer.tv Length: 0 Date: June 11, 2010 Prof Robert A. Burger, speaking at the 2010 ASCO conference: A Phase III trial featured in an ASCO plenary session finds that adding bevacizumab (...

Prof Fred Hirsch of the University of Colorado, Denver Channel: www.ecancer.tv Length: 0 Date: June 08, 2010 Prof Fred Hirsch speaks about the shift towards individualised medication within the treatment of lung cancer. He outlines the role of genetic muta...

Prof Julien Mazieres; University Hospital, Toulouse Channel: www.ecancer.tv Length: 0 Date: June 08, 2010 Prof Julien Mazieres, speaking at the 2010 ELCC conference, discusses chemo circulating cells; the importance of these cells as a prognostic facto...

Prof Jan van Meerbeeck; University Hospital, Ghent, Belgium Channel: www.ecancer.tv Length: 0 Date: June 08, 2010 Prof Jan van Meerbeeck, discuses his research into the use of monoclonal antibodies to treat mesothelioma, a disease generally seen in professiona...

Prof Nico van Zandwijk; University of Sydney Channel: www.ecancer.tv Length: 0 Date: June 07, 2010 Prof Nico van Zandwijk, talking to ecancer.tv at the 2010 ELCC conference, discusses the dangers of asbestos related diseases and his research and...

Prof Paul van Houtte; Institut Jules Bordet, Brussels Channel: www.ecancer.tv Length: 0 Date: June 07, 2010 Prof Paul van Houtte, speaking at the 2010 ELCC conference, discusses the use of targeted radiotherapy to treat lung cancer. Advances such as the ...

Prof Paul Bunn; University of Colorado, Denver Channel: www.ecancer.tv Length: 0 Date: June 07, 2010 Prof Paul Bunn speaks at the 2010 ELCC conference about developments in lung cancer treatments. Prof Bunn discusses the importance of oestrogen rec...

Prof Peter Harper; Kings College, London Channel: www.ecancer.tv Length: 0 Date: June 07, 2010 Prof Peter Harper, speaking at the ELCC conference 2010, talks about research being carried out to address the problems associated with lung cance...

Professor Max Wicha - University of Michigan Comprehensive Cancer Center, USA Channel: www.ecancer.tv Length: 0 Date: May 25, 2010 Professor Wicha, speaking at AACR 2010, talks about research looking at the micro-environment around cancer stem cells, specifically in breast can...

Dr Harvey Pass - New York University Medical Center, USA Channel: www.ecancer.tv Length: 0 Date: May 25, 2010 Dr Pass, talking at AACR 2010, discusses the latest developments in the detection and treatment of mesothelioma, specifically the use of novel bio...

Page: 13 of 30 9 10 11 12 13 14 15 16 17